Jingjing Wang, Senior Associate
Jingjing is a senior associate at Lightstone Ventures evaluating new biopharma investment opportunities. Jingjing has a background in neurobiology and life sciences strategy.
Before joining Lightstone, Jingjing was a Life Sciences Consultant at L.E.K. Consulting, where she worked on projects including target identification, opportunity assessment, corporate strategy, and commercial assessment for large pharmaceutical, mid-cap, and early-stage biotech companies. During her graduate studies, Jingjing was a senior fellow at the Office for Translation & Commercialization at Duke University assessing emerging technologies generated in laboratories at Duke.
Jingjing attained her Ph.D. in neurobiology at Duke University. Her research focused on the molecular and cellular mechanisms of retinal neural circuit formation and glial network development. With an integrated background in sciences and business, Jingjing is excited to help advance innovative life-changing therapeutics for patients in need.
See other team members.